ArticleJournal of clinical immunology2012

Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.

Caroline Veuillen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.